1. 2018
  2. The evolving first-line treatment of advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations

    Decoster, L., Giron, P., Mignon, S. & De Grève, J., Apr 2018, In : Translational Lung Cancer Research. 7, Suppl 2, p. S134-S137

    Research output: Contribution to journalComment/debateResearch

  3. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer

    Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H-J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., Sawyer, M. B., Hendlisz, A., Neyns, B., Svrcek, M., Moss, R. A., Ledeine, J-M., Cao, Z. A., Kamble, S., Kopetz, S. & André, T., 10 Mar 2018, In : Journal of Clinical Oncology. 36, 8, p. 773-779 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Are phase I trials safe for older patients?

    Baldini, C., Le Saux, O., Helissey, C., Aspeslagh, S., Castanon, E., Varga, A., Gazzah, A., Bahleda, R., Mir, O., Massard, C., Soria, J-C. & Hollebecque, A., Mar 2018, In : Journal of Geriatric Oncology. 9, 2, p. 87-92 6 p.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  5. Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS)

    Decoster, L., Kenis, C., Naessens, B., Houbier, G., De Man, M., Lambrecht, G., Monsaert, E., Moons, V., Vergauwe, P., Prenen, H., Van Cutsem, E. & Wildiers, H., Mar 2018, In : Journal of Geriatric Oncology. 9, 2, p. 93-101 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  6. Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

    Le Burel, S., Champiat, S., Routier, E., Aspeslagh, S., Albiges, L., Szwebel, T-A., Michot, J-M., Chretien, P., Mariette, X., Voisin, A-L. & Lambotte, O., Mar 2018, In : Annals of the Rheumatic Diseases. 77, 3, p. 468-470 3 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

    Danlos, F-X., Voisin, A-L., Dyevre, V., Michot, J-M., Routier, E., Taillade, L., Champiat, S., Aspeslagh, S., Haroche, J., Albiges, L., Massard, C., Girard, N., Dalle, S., Besse, B., Laghouati, S., Soria, J-C., Mateus, C., Robert, C., Lanoy, E., Marabelle, A. & 1 othersLambotte, O., Mar 2018, In : European Journal of Cancer. 91, p. 21-29 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. The deubiquitinase USP13 as a novel therapeutic co-target in EGFR mutant non-small cell lung cancer

    Giron, P., Eggermont, C., Noeparast, A., Teugels, E., Gutierrez, G. & De Grève, J., 8 Feb 2018.

    Research output: Unpublished contribution to conferencePosterResearch

  9. Efficacy and tolerability of tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma.

    Sharma, P., Dirix, L., De Vos, F. Y. F. L., Allison, J. P., Decoster, L. & Zaucha, R., 1 Feb 2018, In : Journal of Clinical Oncology. 36, 4, p. 470-470 1 p.

    Research output: Contribution to journalMeeting abstract (Journal)Research

  10. Inadequate glycemic control in patients receiving parenteral nutrition lowers survival: A retrospective observational trial

    Coudenys, E., De Waele, E., Meers, G. & Pen, J., 1 Feb 2018, In : Clinical Nutrition Experimental. 17, p. 1-7 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...51 Next

ID: 25692